Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05926505 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Safety and Efficacy of Anakinra Treatment for Patients With Post Acute Covid Syndrome

Study acronym: PRECISION
StatusRecruiting
PhasePhase 2/3
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary and study completion dates: Aug 2025 to Mar 2028
    • Site details revised at 2 of 24 sites
    v7
  2. Study sites: 23 to 24v6
  3. Site details revised at 1 of 23 sitesv5
  4. Site details revised at 10 of 23 sitesv4
  5. Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 23
    • Primary and study completion dates: Jul 2025 to Aug 2025
    • Start date changed from estimate of Jul 2023 to Sep 6, 2023
    v3
  6. Secondary endpoints revised (5)
    • Eligibility criteria shortened, about 3 words
    • Study description expanded, about 5 words
    v2
  7. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The PRECISION is a proof-of-concept, phase II randomized clinical trial aiming to evaluate the efficacy and safety of anakinra in patients with Post-Acute COVID Syndrome (PACS) of the pro-inflammatory respiratory phenotype. Improvement is measured by a composite endpoint, namely, the "Score of PACS progression reversal"
Trial Details
NCT Number NCT05926505
Lead Sponsor Hellenic Institute for the Study of Sepsis
Conditions
(from sponsor)		 Post-Acute COVID-19 Syndrome, Post-Acute COVID-19, Long COVID
Related terms COVID-19, Post-Acute COVID-19 Syndrome
Enrollment 182 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov